Advanced search
Publication Cover
Expert Review of Obstetrics & Gynecology Volume 8, 2013 - Issue 6
Journal homepage
14
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Risk factors and interventions related to maternal and pre-pregnancy obesity, pre-diabetes and diabetes for maternal, fetal and neonatal outcomes: a systematic review

Zohra S LassiDivision of Women and Child Health, the Aga Khan University, Karachi, Pakistan
&
Zulfiqar A BhuttaDivision of Women and Child Health, the Aga Khan University, Karachi, PakistanCorrespondence[email protected]
Pages 639-660 | Published online: 10 Jan 2014

References

  • Brehm JM, Schuemann B, Fuhlbrigge AL et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 126(1), 52.e5–58.e5 (2010).
  • Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet. Gynecol. Clin. North Am. 34(2), 173–199 (2007).
  • International Diabetes Federation. Diabetes Atlas (5th Edition). International Diabetes Federation, Brussels, Belgium (2012).
  • Bell R, Bailey K, Cresswell T, Hawthorne G, Critchley J, Lewis Barned N. Trends in prevalence and outcomes of pregnancy in women with pre existing type I and type II diabetes. BJOG 115(4), 445–452 (2008).
  • Cheung NW, McElduff A, Ross GP. Type 2 diabetes in pregnancy: a wolf in sheep's clothing. A. N.Z. J. Obstet. Gynaecol. 45(6), 479–483 (2005).
  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25(10), 1862–1868 (2002).
  • Deeks JJ, Altman DG, Bradburn MJ. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-analysis. Egger M, Smith GD, Altman DG ( Eds). BMJ Books, London, UK (2001).
  • Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373(9677), 1773–1779 (2009).
  • Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am. J. Public Health 91(3), 436 (2001).
  • Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP. Pre-pregnancy body mass index and pregnancy outcomes. Int. J. Gynaecol. Obstet. 95(3), 242–247 (2006).
  • Chu SY, Kim SY, Schmid CH et al. Maternal obesity and risk of cesarean delivery: a meta analysis. Obes. Rev. 8(5), 385–394 (2007).
  • Lu GC, Rouse DJ, DuBard M, Cliver S, Kimberlin D, Hauth JC. The effect of the increasing prevalence of maternal obesity on perinatal morbidity Am. J. Obstet. Gynecol. 185(4), 845–849 (2001).
  • Chen CW, Tsai CY, Sung FC et al. Adverse birth outcomes among pregnancies of teen mothers: age specific analysis of national data in Taiwan. Child Care Health Dev. 36(2), 232–240 (2010).
  • Stothard KJ, Tennant PWG, Bell R, Rankin J. Maternal overweight and obesity and the risk of congenital anomalies. JAMA 301(6), 636–650 (2009).
  • Torloni MR, Betren AP, Horta BL et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes. Rev. 10(2), 194–203 (2009).
  • Ota E, Haruna M, Suzuki M et al. Maternal body mass index and gestational weight gain and their association with perinatal outcomes in Viet Nam. Bull. World Health Organ. 89(2), 127–136 (2011).
  • Han YS, Ha EH, Park HS, Kim YJ, Lee SS. Relationships between pregnancy outcomes, biochemical markers and pre-pregnancy body mass index. Int. J. Obes. 35(4), 570–577 (2010).
  • Phithakwatchara N, Titapant V. The effect of pre-pregnancy weight on delivery outcome and birth weight in potential diabetic patients with normal screening for gestational diabetes mellitus in Siriraj Hospital. J. Med. Assoc. Thai. 90(2), 229 (2007).
  • Amarin VN, Akasheh HF. Advanced maternal age and pregnancy outcome. East. Mediterr. Health J. 7(4–5), 646 (2001).
  • Ziadeh S, Yahaya A. Pregnancy outcome at age 40 and older. Arch. Gynecol. Obstet. 265(1), 30–33 (2001).
  • Abu Heija AT, Jallad MF, Abukteish F. Maternal and perinatal outcome of pregnancies after the age of 45. J. Obstet. Gynaecol. Res. 26(1), 27–30 (2000).
  • Ziadeh SM. Maternal and perinatal outcome in nulliparous women aged 35 and older. Gynecol. Obstet. Invest. 54(1), 6–10 (2002).
  • Lin HC, Sheen TC, Tang CH, Kao S. Association between maternal age and the likelihood of a cesarean section: a population based multivariate logistic regression analysis. Acta Obstet. Gynecol. Scand. 83(12), 1178–1183 (2004).
  • Tang CH, Wu MP, Liu JT, Lin HC, Hsu CC. Delayed parenthood and the risk of cesarean delivery – is paternal age an independent risk factor? Birth 33(1), 18–26 (2006).
  • Chan BCP, Lao TTH. Effect of parity and advanced maternal age on obstetric outcome. Int. J. Gynaecol. Obstet. 102(3), 237–241 (2008).
  • Meda N, Traore GS, Meda HA, Curtis V. La mortinatalité au Burkina Faso: facteurs de risque en milieu urbain de Bobo-Dioulasso. Ann. Soc. belge Mod. trop. 71, 307–316 (1991).
  • Khandait DW, Ambadekar NN, Zodpey SP, Vasudeo ND. Maternal age as a risk factor for stillbirth. Indian J. Public Health 44(1), 28–30 (2000).
  • Donoso E, Villarroel L. Reproductive risk of women over 40 years old. Rev. Med. Chil. 131(1), 55 (2003).
  • Ferraz EM, Gray RH. A case-control study of stillbirths in northeast Brazil. Int. J. Gynaecol. Obstet. 34(1), 13–19 (1991).
  • Feresu SA, Harlow SD, Welch K, Gillespie BW. Incidence of stillbirth and perinatal mortality and their associated factors among women delivering at Harare Maternity Hospital, Zimbabwe: a cross-sectional retrospective analysis. BMC Pregnancy Childbirth 5(1), 9 (2005).
  • Seoud MA, Nassar AH, Usta IM, Melhem Z, Kazma A, Khalil AM. Impact of advanced maternal age on pregnancy outcome. Am. J. Perinatol. 19(1), 1 (2002).
  • Gavard JA, Artal R. Effect of exercise on pregnancy outcome. Clin. Obstet. Gynecol. 51(2), 467 (2008).
  • Franz MJ, VanWormer JJ, Crain AL et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J. Am. Diet. Assoc. 107(10), 1755–1767 (2007).
  • McTigue KM, Harris R, Hemphill B et al. Screening and interventions for obesity in adults: summary of the evidence for the US Preventive Services Task Force. Ann. Intern. Med. 139(11), 933 (2003).
  • Poobalan AS, Aucott LS, Gurung T, Smith WCS, Bhattacharya S. Obesity as an independent risk factor for elective and emergency caesarean delivery in nulliparous women – systematic review and meta-analysis of cohort studies. Obes. Rev. 10(1), 28–35 (2009).
  • Guerin A, Nisenbaum R, Ray JG. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes. Diabetes Care 30(7), 1920 (2007).
  • Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth 10(1), 63 (2010).
  • Tieu J, Middleton P, Crowther CA. Preconception care for diabetic women for improving maternal and infant health. Cochrane Database. Syst. Rev. 12(12), Art. No.: CD007776 (2010).
  • Dong ZG, Beischer NA, Wein P, Sheedy MT. Value of early glucose tolerance testing in women who had gestational diabetes in their previous pregnancy. Aust. NZ J. Obstet. Gynaecol. 33(4), 350–357 (1993).
  • Hillier TA, Vesco KK, Pedula KL, Beil TL, Whitlock EP, Pettitt DJ. Screening for gestational diabetes mellitus: a systematic review for the US Preventive Services Task Force. Ann. Intern. Med. 148(10), 766 (2008).
  • Riskin-Mashiah S, Younes G, Damti A, Auslender R. First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 32(9), 1639–1643 (2009).
  • Bergus GR, Murphy NJ. Screening for gestational diabetes mellitus: comparison of a glucose polymer and a glucose monomer test beverage. J. Am. Board. Fam. Pract. 5(3), 241 (1992).
  • Murphy NJ, Meyer BA, O'Kell RT, Hogard ME. Carbohydrate sources for gestational diabetes mellitus screening. J. Reprod. Med. 39(12), 977 (1994).
  • Martinez Collado. JH, Alvarado Gay. FJ, JA. DB, Gonzalez Martinez E. Glucose screening test in pregnant women. A comparison between the traditional glucose load and diet [Tamiz de glucosa en emabarazadas. Comparacion de la carga tradicional contra la dieta]. Medicina Interna de Mexico 19(5), 286–288 (2003).
  • Schmidt MI, Duncan BB, Reichelt AJ et al. Gestational diabetes mellitus diagnosed with a 2-h 75-g oral glucose tolerance test and adverse pregnancy outcomes. Diabetes Care 24(7), 1151–1155 (2001).
  • Ezimokhai M, Joseph A, Bradley-Watson P. Audit of pregnancies complicated by diabetes from one center five years apart with selective versus universal screening. Ann. NY Acad. Sci. 1084(1), 132–140 (2006).
  • Griffin ME, Coffey M, Johnson H et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet. Med. 17(1), 26–32 (2000).
  • Han S, Crowther CA, Middleton P. Interventions for pregnant women with hyperglycaemia not meeting gestational diabetes and type 2 diabetes diagnostic criteria. Cochrane Database. Syst. Rev. 1(1), CD009037 (2012).
  • Bevier WC, Fischer R, Jovanovic L. Treatment of women with an abnormal glucose challenge test (but a normal oral glucose tolerance test) decreases the prevalence of macrosomia. Am. J. Perinatol. 16, 269–276 (1999).
  • Bonomo M, Corica D, Mion E et al. Evaluating the therapeutic approach in pregnancies complicated by borderline glucose intolerance: a randomized clinical trial. Diabet. Med. 22(11), 1536–1541 (2005).
  • Grant SM, Wolever T, O'Connor DL, Nisenbaum R, Josse RG. Effect of a low glycaemic index diet on blood glucose in women with gestational hyperglycaemia. Diabetes Res. Clin. Pract. 91(1), 15–22 (2011).
  • Langer O, Anyaegbunam A, Brustman L, Divon M. Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am. J. Obstet. Gynecol. 161(3), 593 (1989).
  • Clapp JF. Maternal carbohydrate intake and pregnancy outcome. In: Proceedings of the Nutrition Society. Cambridge Univ Press, Cambridge, UK, 45–50 (2002).
  • Fraser RB, Ford FA, Milner RDG. A controlled trial of a high dietary fibre intake in pregnancy – effects on plasma glucose and insulin levels. Diabetologia 25(3), 238–241 (1983).
  • Moses RG, Luebcke M, Davis WS et al. Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes. Am. J. Clin. Nutr. 84(4), 807–812 (2006).
  • Avery MD, Leon AS, Kopher RA. Effects of a partially home-based exercise program for women with gestational diabetes. Obstet. Gynecol. 89(1), 10–15 (1997).
  • Brankston GN, Mitchell BF, Ryan EA, Okun NB. Resistance exercise decreases the need for insulin in overweight women with gestational diabetes mellitus. Am. J. Obstet. Gynecol. 190(1), 188–193 (2004).
  • Bung P, Artal R, Khodiguian N. Regular exercise therapy in disturbed carbohydrate metabolism during pregnancy results of a prospective randomised longitudinal study. Geburtshilfe Frauenheilkd 53, 188–193 (1993).
  • Jovanovic-Peterson L, Peterson CM. Is exercise safe or useful for gestational diabetic women? Diabetes 40( Suppl. 2), S179–S181 (1991).
  • Langer O, Conway DL, Berkus MD, Xenakis EMJ, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N. Engl. J. Med. 343(16), 1134–1138 (2000).
  • Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. N. Engl. J. Med. 358(19), 2003–2015 (2008).
  • Hague WM, Davoren PM, Oliver J, Rowan JA. Contraindications to use of metformin-Metformin may be useful in gestational diabetes. BMJ 326(7392), 762–763 (2003).
  • Moore L, Briery C, Martin R, Hood E, Bofill J, Morrison J. Metformin (M) vs. insulin (I) in A2 diabetes: a randomized clinical trial [abstract]. Am. J. Obstet. Gynecol. 191(6 Suppl. 1), S8 (2004).
  • Anjalakshi C, Balaji V, Balaji MS, Seshiah V. A prospective study comparing insulin and glibenclamide in gestational diabetes mellitus in Asian Indian women. Diabetes Res. Clin. Pract. 76(3), 474–475 (2007).
  • Bertini AM, Silva JC, Taborda W et al. Perinatal outcomes and the use of oral hypoglycemic agents. J. Perinat. Med. 33(6), 519–523 (2005).
  • Ekpebegh CO, Coetzee EJ, Van Der Merwe L, Levitt NS. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabet. Med. 24(3), 253–258 (2007).
  • Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet. Med. 17(7), 507–511 (2000).
  • Holt RIG, Clarke P, Parry EC, Coleman MAG. The effectiveness of glibenclamide in women with gestational diabetes. Diabetes Obes. Metab. 10(10), 906–911 (2008).
  • Hughes RCE, Rowan JA. Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome? Diabet. Med. 23(3), 318–322 (2006).
  • Rayburn WF, Sokkary N, Clokey DE, Moore LE, Curet LB. Consequences of routine delivery at 38 weeks for A-2 gestational diabetes. J. Matern. Fetal Neonatal Med. 18(5), 333 (2005).
  • Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J. Perinatol. 24(10), 617–622 (2004).
  • Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet. Gynecol. 104(1), 88–93 (2004).
  • Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J. Matern. Fetal Neonatal Med. 15, 51–55 (2004).
  • Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am. J. Obstet. Gynecol. 193(1), 118–124 (2005).
  • Rochon M, Rand L, Roth L, Gaddipati S. Glyburide for the management of gestational diabetes: risk factors predictive of failure and associated pregnancy outcomes. Am. J. Obstet. Gynecol. 195(4), 1090–1094 (2006).
  • Hod M, Damm P, Kaaja R et al. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am. J. Obstet. Gynecol. 198(2), e181–186 e187 (2008).
  • Persson B, Swahn ML, Hjertberg R et al. Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus. Diabetes Res. Clin. Pract. 58(2), 115–121 (2002).
  • AydIn Y, Berker D, Direktor N et al. Is insulin lispro safe in pregnant women: does it cause any adverse outcomes on infants or mothers? Diabetes Res. Clin. Pract. 80(3), 444–448 (2008).
  • Negrato CA, Rafacho A, Negrato G et al. Glargine vs NPH insulin therapy in pregnancies complicated by diabetes: an observational cohort study. Diabetes Res. Clin. Pract. 89(1), 46–51 (2010).
  • Mukhopadhyay. A, Farrell. T, Fraser. RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and meta-analysis of randomized, controlled trials. Am. J. Obstet. Gynecol. 197(5), 447–456 (2007).
  • Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst. Rev. 3(3), CD005542 (2007).
  • Coustan DR, Reece EA, Sherwin RS et al. A randomized clinical trial of the insulin pump vs intensive conventional therapy in diabetic pregnancies. JAMA 255(5), 631–636 (1986).
  • Laatikainen L, Teramo K, Hieta-Heikurainen H, Koivisto V, Pelkonen R. A controlled study of the influence of continuous subcutaneous insulin infusion treatment on diabetic retinopathy during pregnancy. Acta Med. Scand. 221(4), 367–376 (1987).
  • Botta RM, Sinagra D, Angelico MC, Bompiani GD. Comparison of intensified traditional insulin therapy and micropump therapy in pregnant women with type 1 diabetes mellitus]. Minerva. Med. 77(17), 657 (1986).
  • Burkart W, Hanker JP, Schneider HPG. Complications and fetal outcome in diabetic pregnancy. Gynecol. Obstet. Invest. 26(2), 104–112 (1988).
  • Carta Q, Meriggi E, Trossarelli GF et al. Continuous subcutaneous insulin infusion versus intensive conventional insulin therapy in type I and type II diabetic pregnancy. Diabete. Metab. 12(3), 121 (1986).
  • Nosari I, Maglio ML, Lepore G, Cortinovis F, Pagani G. Is continuous subcutaneous insulin infusion more effective than intensive conventional insulin therapy in the treatment of pregnant diabetic women? Diabetes Nutr. Metab. 6(1), 33–37 (1993).
  • Trossarelli G, Cavallo-Perin P, Meriggi E et al. Metabolic and obstetrical results in Type 1 (insulin-dependent) diabetic pregnancy: pump versus optimized conventional insulin therapy [abstract]. Diabetologia 27(2), 340A (1984).
  • Mello G, Parretti E, Tondi F, Riviello C, Borri P, Scarselli G. Impact of two treatment regimens with insulin lispro in post-prandial glucose excursion patterns and fetal fat mass growth in type 1 diabetic pregnant women [abstract]. Am. J. Obstet. Gynecol. 193(6), S36–S36 (2005).
  • Hieronimus S, Cupelli C, Bongain A, Durand-Reville M, Berthier F, Fenichel P. Pregnancy in type 1 diabetes: insulin pump versus intensified conventional therapy. Gynecol. Obstet. Fertil. 33(6), 389 (2005).
  • Tieu J, Crowther CA, Middleton P. Dietary advice in pregnancy for preventing gestational diabetes mellitus. Cochrane Database Syst. Rev. 2(2), CD006674 (2008).
  • Alwan N, Tuffnell DJ, West J. Treatments for gestational diabetes. Cochrane Database Syst. Rev. 3(3), CD003395 (2009).
  • Syed M, Javed H, Yakoob MY, Bhutta Z. Effect of screening and management of diabetes during pregnancy on stillbirths. BMC Public Health 11( Suppl. 3), S2 (2011).
  • Tuffnell DJ, West J, Walkinshaw SA. Treatments for gestational diabetes and impaired glucose tolerance in pregnancy. Cochrane Database. Syst. Rev. 3(3), Art. No.: CD003395 (2009).
  • Bancroft K, Tuffnell DJ, Mason GC, Rogerson LJ, Mansfield M. A randomised controlled pilot study of the management of gestational impaired glucose tolerance. BJOG 107(8), 959–963 (2000).
  • Langer O, Rodriguez DA, Xenakis EM, McFarland MB, Berkus MD, Arrendondo F. Intensified versus conventional management of gestational diabetes. Am. J. Obstet. Gynecol. 170(4), 1036–1046 (1994).
  • Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 352(24), 2477–2486 (2005).
  • Garner P, Okun N, Keely E et al. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am. J. Obstet. Gynecol. 177(1), 190–195 (1997).
  • Landon MB, Spong CY, Thom E et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 361(14), 1339–1348 (2009).
  • Gillen LJ, Tapsell LC. Advice that includes food sources of unsaturated fat supports future risk management of gestational diabetes mellitus. J. Am. Diet. Assoc. 104(12), 1863–1867 (2004).
  • Berne C, Wibell L, Lindmark G. Ten-year Experience of Insulin Treatment in Gestational Diabetes. Acta Paediatr. 74, 85–93 (1985).
  • Coetzee EJ, Jackson WPU. Diabetes newly diagnosed during pregnancy. S. Afr. Med. J. 56, 467–475 (1979).
  • Coetzee EJ, Jackson WPU. Pregnancy in established non-insulin-dependent diabetics. S. Afr. Med. J. 58, 795–802 (1980).
  • Crombach G, Wolff F, Klein W et al. [Pregnancy outcome with intensified insulin therapy in manifest diabetes]. Geburtshilfe Frauenheilkd 50(4), 263 (1990).
  • Huddle K, England M, Nagar A. Outcome of pregnancy in diabetic women in Soweto, South Africa 1983–1992. Diabet. Med. 10(3), 290–294 (1993).
  • Huddle KR. Audit of the outcome of pregnancy in diabetic women in Soweto, South Africa, 1992–2002. S. Afr. Med. J. 10(3), 102–107 (2008).
  • Koukkou E, Taub N, Jackson P, Metcalfe G, Cameron M, Lowy C. Difference in prevalence of gestational diabetes and perinatal outcome in an innercity multiethnic London population. Eur. J. Obstet. Gynecol. Reprod. Biol. 59(2), 153–157 (1995).
  • Philipson EH, Kalhan SC, Rosen MG, Edelberg SC, Williams TG, Riha MM. Gestational diabetes mellitus. Is further improvement necessary? Diabetes 34, 55 (1985).
  • Al-Dabbous IA, Owa JA, Nasserallah ZA, Al-Qurash IS. Perinatal moribidity and mortality in offspring of diabetic mothers in Qatif, Saudi Arabia. Eur. J. Obstet. Gynecol. Reprod. Biol. 65(2), 165–169 (1996).
  • Beischer NA, Wein P, Sheedy MT, Steffen B. Identification and treatment of women with hyperglycaemia diagnosed during pregnancy can significantly reduce perinatal mortality rates. Aust. NZ J. Obstet. Gynaecol. 36(3), 239–247 (1996).
  • Banerjee S, Ghosh US, Banerjee D. Effect of tight glycaemic control on fetal complications in diabetic pregnancies. J. Assoc. Physicians. India 52, 109–113 (2004).
  • Mirghani OA, Saeed OK. A simplified management of diabetic pregnant women. Diabetes Care 24(7), 1129 (2001).
  • Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 325(7375), 1275–1276 (2002).
  • Gonzalez-Quintero VH, Istwan NB, Rhea DJ et al. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care 30(3), 467–470 (2007).
  • Nachum Z, Ben-Shlomo I, Weiner E, Ben-Ami M, Shalev E. Diabetes in pregnancy: efficacy and cost of hospitalization as compared with ambulatory management: a prospective controlled study. Isr. Med. Assoc. J. 3(12), 915–919 (2001).
  • Traub AI, Harley JMG, Cooper TK, Maguiness SD, Hadden DR. Is centralized hospital care necessary for all insulin-dependent pregnant diabetics? BJOG 94(10), 957–962 (1987).
  • Bhutta ZA, Yakoob MY, Lawn JE et al. Stillbirths: what difference can we make and at what cost? Lancet 377(9776), 1523–1538 (2011).
  • Abenhaim HA, Kinch RA, Morin L, Benjamin A, Usher R. Effect of prepregnancy body mass index categories on obstetrical and neonatal outcomes. Arch. Gynecol. Obstet. 275(1), 39–43 (2007).
  • Chu SY, Bachman DJ, Callaghan WM et al. Association between obesity during pregnancy and increased use of health care. N. Engl. J. Med. 358(14), 1444 (2008).
  • Murakami M, Ohmichi M, Takahashi T et al. Prepregnancy body mass index as an important predictor of perinatal outcomes in Japanese. Arch. Gynecol. Obstet. 271(4), 311–315 (2005).
  • Nohr EA, Vaeth M, Baker JL, Sorensen TIA, Olsen J, Rasmussen KM. Combined associations of prepregnancy body mass index and gestational weight gain with the outcome of pregnancy. Am. J. Clin. Nutr. 87(6), 1750 (2008).
  • Callaway LK, Prins JB, Chang AM, McIntyre HD. The prevalence and impact of overweight and obesity in an Australian obstetric population. Med. J. Aust. 184(2), 56 (2006).
  • Sebire NJ, Jolly M, Harris JP et al. Maternal obesity and pregnancy outcome: a study of 287213 pregnancies in London. Int. J. Obes. 25(8), 1175–1182 (2001).
  • Cleary-Goldman J, Malone FD, Vidaver J et al. Impact of maternal age on obstetric outcome. Obstet. Gynecol. 105(5 Pt 1), 983 (2005).
  • Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40: pregnancy outcome in 24,032 cases. Obstet. Gynecol. 93(1), 9 (1999).
  • Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet. Gynecol. 104(4), 727 (2004).
  • Joseph KS, Allen AC, Dodds L, Turner LA, Scott H, Liston R. The perinatal effects of delayed childbearing. Obstet. Gynecol. 105(6), 1410 (2005).
  • Dempsey JC, Butler CL, Sorensen TK, Lee I. A case-control study of maternal recreational physical activity and risk of gestational diabetes mellitus. Diabetes Res. Clin. Pract. 66(2), 203–215 (2004).
  • Dempsey JC, Sorensen TK, Williams MA, Lee I. Prospective study of gestational diabetes mellitus risk in relation to maternal recreational physical activity before and during pregnancy. Am. J. Epidemiol. 159(7), 663 (2004).
  • Oken E, Ning Y, Rifas-Shiman SL, Radesky JS, Rich-Edwards JW, Gillman MW. Associations of physical activity and inactivity before and during pregnancy with glucose tolerance. Obstet. Gynecol. 108(5), 1200 (2006).
  • Rudra CB, Williams MA, Lee I. Perceived exertion in physical activity and risk of gestational diabetes mellitus. Epidemiology 17(1), 31 (2006).
  • Tobias DK, Zhang C, van Dam RM, Bowers K, Hu FB. Physical Activity Before and During Pregnancy and Risk of Gestational Diabetes Mellitus. Diabetes Care 34(1), 223 (2011).
  • Zhang C, Solomon CG, Manson JAE, Hu FB. A prospective study of pregravid physical activity and sedentary behaviors in relation to the risk for gestational diabetes mellitus. Arch. Intern. Med. 166(5), 543 (2006).
  • Boulot P, Chabbert-Buffet N, d'Ercole C et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 26(11), 2990 (2003).
  • Damm P, Molsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am. J. Obstet. Gynecol. 161(5), 1163–1167 (1989).
  • Pregnancy outcomes in the Diabetes Control and Complications Trial. Am. J. Obstet. Gynecol. 174(4), 1343–1353 (1996).
  • Dicker D, Feldberg D, Samuel N, Yeshaya A, Karp M, Goldman JA. Spontaneous abortion in patients with insulin-dependent diabetes mellitus: the effect of preconceptional diabetic control. Am. J. Obstet. Gynecol. 158(5), 1161–1164 (1988).
  • Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 6(3), 219–223 (1983).
  • Fuhrmann K, Reiher H, Semmler K, Glockner E. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp. Clin. Endocrinol. 83(2), 5 (1984).
  • Galindo A, Garcia Burguillo A, Azriel S, De La Fuente P, Artal R. Outcome of fetuses in women with pregestational diabetes mellitus. J. Perinat. Med. 34(4), 323–332 (2006).
  • Garcia-Patterson A, Corcoy R, Rigla M et al. Does preconceptional counselling in diabetic women influence perinatal outcome? Ann. Ist. Super. Sanita 33(3), 333–336 (1997).
  • Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am. J. Obstet. Gynecol. 155(2), 293–297 (1986).
  • Jaffiol C, Baccara MT, Renard E et al. [Evaluation of the benefits brought by pregnancy planning in type 1 diabetes mellitus]. Bull. Acad. Natl Med. 184(5), 995–1007, discussion 1007–1008 (2000).
  • Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes. JAMA 265(6), 731 (1991).
  • McElvy SS, Miodovnik M, Rosenn B et al. A focused preconceptional and early pregnancy program in women with type 1 diabetes reduces perinatal mortality and malformation rates to general population levels. J. Matern. Fetal Neonatal Med. 9(1), 14–20 (2000).
  • Mills JL, Knopp RH, Simpson JL et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N. Engl. J. Med. 318(11), 671–676 (1988).
  • Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Pre-conception management of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet. Gynecol. 77(6), 846–849 (1991).
  • Rowe BR, Rowbotham CJ, Barnett AH. Pre-conception counselling, birth weight, and congenital abnormalities in established and gestational diabetic pregnancy. Diabetes Res. 6(1), 33 (1987).
  • Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ 301(6760), 1070 (1990).
  • Temple RC, Aldridge V, Stanley K, Murphy HR. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG 113(11), 1329–1332 (2006).
  • Willhoite MB, Bennert HWJr, Palomaki GE et al. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 16(2), 450–455 (1993).
  • Dunne FP, Brydon P, Smith T, Essex M, Nicholson H, Dunn J. Pre-conception diabetes care in insulin-dependent diabetes mellitus. QJM 92(3), 175 (1999).
  • Garcia Ingelmo MT, Herranz de la Morena L, Martin Vaquero P, Janez Furio M, Grande Aragon C, Pallardo Sanchez LF. [Preconceptional control in diabetic women]. Rev. Clin. Esp. 198(2), 80–84 (1998).
  • Jensen BM, Kuhl C, Molsted-Pedersen L, Saurbrey N, Fog-Pedersen J. Preconceptional treatment with insulin infusion pumps in insulin-dependent diabetic women with particular reference to prevention of congenital malformations. Acta Endocrinol. Suppl. 277, 81–85 (1986).
  • Murphy LE, Gollenberg AL, Louis GMB, Kostyniak PJ, Sundaram R. Maternal serum preconception polychlorinated biphenyl concentrations and infant birth weight. Environ. Health Perspect. 118(2), 297 (2010).
  • Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 29(8), 1744 (2006).
  • Bhutta ZA, Cabral S, Chan C, Keenan WJ. Reducing maternal, newborn, and infant mortality globally: an integrated action agenda. Int. J. Gyn. Obst. 119, S13–S17 (2012).
  • Fortner RT, Pekow P, Solomon CG, Markenson G, Chasan-Taber L. Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women. Am. J. Obstet. Gynecol. 200(2), 167–167 (2009).
  • Samuels-Kalow ME, Funai EF, Buhimschi C et al. Prepregnancy body mass index, hypertensive disorders of pregnancy, and long-term maternal mortality. Am. J. Obstet. Gynecol. 197(5), 490 (2007).
  • Jensen DM, Damm P, Sørensen B et al. Pregnancy outcome and prepregnancy body mass index in 2459 glucose-tolerant Danish women. Am. J. Obstet. Gynecol. 189(1), 239–244 (2003).
  • Leeners B, Rath W, Kuse S, Irawan C, Imthurn B, Neumaier-Wagner P. BMI: new aspects of a classical risk factor for hypertensive disorders in pregnancy. Clin. Sci. 111, 81–86 (2006).
  • Saftlas AF, Wang W, Risch H, Woolson R, Hsu CD, Bracken MB. Prepregnancy body mass index and gestational weight gain as risk factors for preeclampsia and transient hypertension. Ann. Epidemiol. 10(7), 475–475 (2000).
  • Driul L, Cacciaguerra G, Citossi A, Martina MD, Peressini L, Marchesoni D. Prepregnancy body mass index and adverse pregnancy outcomes. Arch. Gynecol. Obstet. 278(1), 23–26 (2008).
  • Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet. Gynecol. 103(2), 219 (2004).
  • LaCoursiere D, Bloebaum L, Duncan JD, Varner MW. Population-based trends and correlates of maternal overweight and obesity, Utah 1991–2001. Am. J. Obstet. Gynecol. 192(3), 832–839 (2005).
  • Getahun D, Ananth CV, Peltier MR, Salihu HM, Scorza WE. Changes in prepregnancy body mass index between the first and second pregnancies and risk of large-for-gestational-age birth. Am. J. Obstet. Gynecol. 196(6), 530 (2007).
  • Barau G, Robillard P. Linear association between maternal pre pregnancy body mass index and risk of caesarean section in term deliveries. BJOG 113(10), 1173–1177 (2006).
  • Kaiser PS, Kirby RS. Obesity as a risk factor for cesarean in a low-risk population. Obstet. Gynecol. 97(1), 39 (2001).
  • Vahratian A, Siega-Riz AM, Savitz DA, Zhang J. Maternal pre-pregnancy overweight and obesity and the risk of cesarean delivery in nulliparous women. Ann. Epidemiol. 15(7), 467–474 (2005).
  • Chen A, Klebanoff MA, Basso O. Pre-pregnancy body mass index change between pregnancies and preterm birth in the following pregnancy. Paediatr. Perinat. Epidemiol. 23(3), 207–215 (2009).
  • Johnson TS, Rottier KJ, Luellwitz A, Kirby RS. Maternal prepregnancy body mass index and delivery of a preterm infant in Missouri 1998–2000. Public Health Nurs. 26(1), 3–13 (2009).
  • Kosa JL, Guendelman S, Pearl M, Graham S, Abrams B, Kharrazi M. The association between pre-pregnancy BMI and preterm delivery in a diverse southern california population of working women. Matern. Child Health J. 15(6), 772–781 (2010).
  • Wise LA, Palmer JR, Heffner LJ, Rosenberg L. Prepregnancy body size, gestational weight gain, and risk of preterm birth in African-American women. Epidemiology 21(2), 243 (2010).
  • Kristensen J, Vestergaard M, Wisborg K, Kesmodel U, Secher NJ. Pre pregnancy weight and the risk of stillbirth and neonatal death. BJOG 112(4), 403–408 (2005).
  • Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, Olsen J. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet. Gynecol. 61(1), 7 (2005).
  • Frederick IO, Rudra CB, Miller RS, Foster JC, Williams MA. Adult weight change, weight cycling, and prepregnancy obesity in relation to risk of preeclampsia. Epidemiology 17(4), 428 (2006).
  • Gilboa SM, Correa A, Alverson CJ. Use of spline regression in an analysis of maternal prepregnancy body mass index and adverse birth outcomes: does it tell us more than we already know? Ann. Epidemiol. 18(3), 196–205 (2008).
  • Luke B, Brown MB. Elevated risks of pregnancy complications and adverse outcomes with increasing maternal age. Hum. Reprod. 22(5), 1264 (2007).
  • Miller DA. Is advanced maternal age an independent risk factor for uteroplacental insufficiency? Am. J. Obstet. Gynecol. 192(6), 1974–1980 (2005).
  • Bell JS, Campbell DM, Graham WJ, Penney GC, Ryan M, Hall MH. Can obstetric complications explain the high levels of obstetric interventions and maternity service use among older women? A retrospective analysis of routinely collected data. BJOG 108(9) 910–918 (2001).
  • Bianco A, Stone J, Lynch L, Lapinski R, Berkowitz G, Berkowitz RL. Pregnancy outcome at age 40 and older. Obstet. Gynecol. 87(6), 917–922 (1996).
  • Bobrowski RA, Bottoms SF. Underappreciated risks of the elderly multipara. Am. J. Obstet. Gynecol. 172(6), 1764–1767 (1995).
  • Chen G, Uryasev S, Young TK. On prediction of the cesarean delivery risk in a large private practice. Am. J. Obstet. Gynecol. 191(2), 616–623 (2004).
  • Cnattingius R, Cnattingius S, Notzon FC. Obstacles to reducing cesarean rates in a low-cesarean setting: the effect of maternal age, height, and weight. Obstet. Gynecol. 92(4), 501–506 (1998).
  • Delbaere I, Verstraelen H, Goetgeluk S, Martens G, De Backer G, Temmerman M. Pregnancy outcome in primiparae of advanced maternal age. Eur. J. Obstet. Gynecol. Reprod. Biol. 135(1), 41–46 (2007).
  • Gordon D, Milberg J, Daling J, Hickok D. Advanced maternal age as a risk factor for cesarean delivery. Obstet. Gynecol. 77(4), 493 (1991).
  • Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum. Reprod. 15(11), 2433 (2000).
  • Kirchengast S, Hartmann B. Advanced maternal age is not only associated with newborn somatometrics but also with the mode of delivery. Ann. Hum. Biol. 30(1), 1–12 (2003).
  • O’Leary CM, De Klerk N, Keogh J et al. Trends in mode of delivery during 1984–2003: can they be explained by pregnancy and delivery complications? BJOG 114(7), 855–864 (2007).
  • Prysak M, Lorenz RP, Kisly A. Pregnancy outcome in nulliparous women 35 years and older. Obstet. Gynecol. 85(1), 65–70 (1995).
  • Roberts CL, Algert CS, Carnegie M, Peat B. Operative delivery during labour: trends and predictive factors. Paediatr. Perinat. Epidemiol. 16(2), 115–123 (2002).
  • Treacy A, Robson M, O'Herlihy C. Dystocia increases with advancing maternal age. Am. J. Obstet. Gynecol. 195(3), 760–763 (2006).
  • Yuan W, Steffensen FH, Nielsen GL, Møller M, Olsen J, Sørensen HT. A population-based cohort study of birth and neonatal outcome in older primipara. Int. J. Gynaecol. Obstet. 68(2), 113–118 (2000).
  • Astolfi P, Zonta LA. Delayed maternity and risk at delivery. Paediatr. Perinat. Epidemiol. 16(1), 67–72 (2002).
  • Astolfi P, De Pasquale A, Zonta L. Late childbearing and its impact on adverse pregnancy outcome: stillbirth, preterm delivery and low birth weight. Rev. Epidemiol. Sante Publique 53, 97–105 (2005).
  • Canterino JC, Ananth CV, Smulian J, Harrigan JT, Vintzileos AM. Maternal age and risk of fetal death in singleton gestations: USA, 1995–2000. J. Matern. Fetal Neonatal Med. 15(3), 193–197 (2004).
  • Conde-Agudelo A, Belizán JM, Díaz-Rossello JL. Epidemiology of fetal death in Latin America. Acta Obstet. Gynecol. Scand. 79(5), 371–378 (2000).
  • Feldman GB. Prospective risk of stillbirth. Obstet. Gynecol. 79(4), 547 (1992).
  • Fretts RC, Schmittdiel J, McLean FH, Usher RH, Goldman MB. Increased maternal age and the risk of fetal death. N. Engl. J. Med. 333(15), 953–957 (1995).
  • Fretts RC, Usher RH. Causes of fetal death in women of advanced maternal age. Obstet. Gynecol. 89(1), 40–45 (1997).
  • Gadow EC, Castilla EE, Lopez Camelo J, Queenan JT. Stillbirth rate and associated risk factors among 869 750 Latin American hospital births 1982–1986. Int. J. Gynaecol. Obstet. 35(3), 209–214 (1991).
  • Glinianaia SV, Rankin J, Bell R, Pearce MS, Parker L. Temporal changes in the distribution of population risk factors attenuate the reduction in perinatal mortality. J. Clin. Epidemiol. 58(12), 1299–1307 (2005).
  • Haglund B, Cnattingius S, Nordström ML. Social differences in late fetal death and infant mortality in Sweden 1985–86. Paediatr. Perinat. Epidemiol. 7(1), 33–44 (1993).
  • Heimann F, Messerer D, Baltzer J. [Pregnancy, labor and fetal outcome in females over 40 years of age]. Geburtshilfe Frauenheilkd 53(6), 411 (1993).
  • Lammer EJ, Brown LE, Anderka MT, Guyer B. Classification and analysis of fetal deaths in Massachusetts. JAMA 261(12), 1757 (1989).
  • Naeye RL. Maternal age, obstetric complications, and the outcome of pregnancy. Obstet. Gynecol. 61(2), 210 (1983).
  • Nybo Andersen AMN, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 320(7251), 1708 (2000).
  • Pugliese A, Vicedomini D, Arsieri R. Perinatal outcomes of newborn infants of mothers over 40 years old. A case-control study. Minerva Ginecol. 49(3), 81 (1997).
  • Rasmussen S, Albrechtsen S, Irgens LM et al. Risk factors for unexplained antepartum fetal death in Norway 1967–1998. Early Hum. Dev. 71(1), 39–52 (2003).
  • Raymond EG, Cnattingius S, Kiely JL. Effects of maternal age, parity, and smoking on the risk of stillbirth. BJOG 101(4), 301–306 (1994).
  • Reddy UM, Ko CW, Willinger M. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am. J. Obstet. Gynecol. 195(3), 764–770 (2006).
  • Roman H, Robillard PY, Julien C et al. Pregnancy beyond age 40 in 382 women: a retrospective study in Reunion Island. J. Gynecol. Obstet. Biol. Reprod. 33(7), 615 (2004).
  • Sheiner E, Hallak M, Shoham-Vardi I, Goldstein D, Mazor M, Katz M. Determining risk factors for intrapartum fetal death. J. Reprod. Med. 45(5), 419 (2000).
  • Tough SC, Newburn-Cook C, Johnston DW, Svenson LW, Rose S, Belik J. Delayed childbearing and its impact on population rate changes in lower birth weight, multiple birth, and preterm delivery. Pediatrics 109(3), 399 (2002).
  • Viegas OAC, Leong WP, Ahmed S, Ratnam SS. Obstetrical outcome with increasing maternal age. J. Biosoc. Sci. 26(02), 261–267 (1994).
  • Little RE, Weinberg CA. Risk factors for antepartum and intrapartum stillbirth. Am. J. Epidemiol. 137(11), 1177 (1993).
  • Petridou E, Kotsifakis G, Revinthi K, Polychronopoulou A, Trichopoulos D. Determinants of stillbirth mortality in Greece. Soz. Praventivmed. 41(2), 70–78 (1996).
  • Smeeton NC, Rona RJ, Dobson P, Cochrane R, Wolfe C. Assessing the determinants of stillbirths and early neonatal deaths using routinely collected data in an inner city area. BMC Med. 2(1), 27 (2004).
  • Stephansson O, Dickman PW, Johansson ALV, Cnattingius S. The influence of socioeconomic status on stillbirth risk in Sweden. Int. J. Epidemiol. 30(6), 1296 (2001).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.